This news release for
Sagicor Financial Company Ltd. ("Sagicor" or the "Company") should
be read in conjunction with the Company's Management's Discussion
& Analysis ("MD&A") and the Consolidated Financial
Statements for the period ended September 30, 2022. These documents
are available on Sagicor's website, at www.sagicor.com, under the
heading "Financials and Filings", and under Sagicor's profile at
www.sedar.com. This news release presents non-IFRS measures used by
Sagicor in evaluating its results and measuring its performance.
These non-IFRS measures are not standardized financial measures,
are not included in the Consolidated Financial Statements, and may
not be comparable to similar financial measures used by other
companies. They include return on shareholders' equity, book value
per share, debt to capital ratio and total capital. See the
"Non-IFRS Measures" section in this document for relevant
information about such measures.
|
|
TORONTO AND BARBADOS, Nov. 11,
2022 /CNW/ - Sagicor Financial Company Ltd. (TSX:
SFC), a leading financial services provider in the Caribbean with a growing presence in the U.S.,
today announced its results for the third quarter ended
September 30, 2022. All figures are
in US$ unless otherwise stated.
Highlights
- Total revenue of $656.1
million for Q3 decreased 16% Y/Y, $2,009.0 million for the YTD increased 16%
Y/Y
- Net insurance premiums of $526.5
million for Q3 decreased 16% Y/Y, $1,695.7 million for the YTD increased 34%
Y/Y
- Net income to shareholders of $25.4 million in Q3, $102.5 million YTD
- Earnings per share of US$0.178 or C$0.232
in Q3, US$0.717 or C$0.920 YTD
- Return on shareholders' equity
(annualised)(1) of 9.8% in Q3, 13.2% YTD
- Book value per share(1) of
US$7.25 or C$9.96 in Q3
- Dividend of US$0.05625 per
common share to be paid during the fourth quarter of 2022
(US$0.225 annualised dividend)
Dodridge Miller, Group
President and Chief Executive Officer, said:
"The Sagicor Group delivered solid results for the quarter in
the face of a volatile market and rising rate environment. Asset
price volatility continued to foster a favorable environment for us
to grow premiums and invest at higher yields, which particularly
benefited Sagicor Life USA again
this quarter. Sagicor Jamaica had a strong quarter as it saw net
premium revenue growth across all major business lines, while
Sagicor Life was impacted by higher benefits and charges that are
non-recurring in nature. In the quarter we also announced the
acquisition of ivari, a transformational addition to our Group
which we expect to close in 2023."
_______________________
|
(1)
|
Represents a non-IFRS
measure. See the Non-IFRS Measures section in this document and in
our MD&A for relevant information about such
measures.
|
Consolidated
Highlights
|
|
|
|
|
|
|
Profitability
(US$ millions)
|
Q3
2022
|
Q3
2021
|
Change
|
YTD
2022
|
YTD
2021
|
Change
|
Total
revenue
|
656.1
|
781.9
|
(16 %)
|
2,009.0
|
1,729.6
|
16 %
|
Net income to
shareholders
|
25.4
|
50.4
|
(50 %)
|
102.5
|
91.2
|
12 %
|
Annualised return on
shareholders' equity(1) (%)
|
9.8 %
|
18.5 %
|
(8.7 pts)
|
13.2 %
|
11.3 %
|
1.9 pts
|
|
|
|
|
|
|
|
|
|
|
Financial
Strength (US$ millions)
|
Q3
2022
|
Q3
2021
|
Change
|
Shareholders'
equity
|
1,035
|
1,134
|
(9 %)
|
Book value per
share(1) (US$ per share)
|
7.25
|
7.92
|
(8 %)
|
MCCSR
ratio(1) (%)
|
204 %
|
247 %
|
(43 pts)
|
Debt to capital
ratio(1) (%)
|
31.0 %
|
24.4 %
|
6.6 pts
|
Total
capital(1)
|
2,066
|
2,233
|
(7 %)
|
Overall Sagicor Group - Quarterly
Highlights
- Net income to shareholders of $25.4 million for the quarter was down
year-over-year as compared to an exceptionally strong Q3 2021.
Profitability during the quarter was driven by robust sales of
annuities and favorable asset spreads in our Sagicor Life
USA segment as well as a strong
quarter by Sagicor Jamaica which saw its life insurance business
benefit from rising interest rates. Sagicor Life's solid revenue
was more than offset by negative claims experience, a one-time
Pandemic Levy by the Government of Barbados, and a strengthening of reserves.
- Total capital(1) of $2,066 million was down compared to the prior
quarter primarily due to the mark-to-market losses incurred through
Other Comprehensive Income on the Group's bond portfolio from a
rise in interest rates which affected shareholders' equity and the
divestiture of Sagicor Real Estate X Fund at Sagicor Jamaica which
led to the decline in non-controlling interest. The Company's
MCCSR ratio(1) for its insurance businesses was
204% and the Company's debt to capital ratio(1)
was 31.0%.
Dividends
On November 10, 2022, the Board of
Directors of Sagicor Financial Company Ltd. approved and declared a
quarterly dividend of US$0.05625 per
common share. This quarterly dividend will be paid on December 14, 2022, to shareholders of record at
the close of business on November 23,
2022. This is the twelfth dividend payment Sagicor will pay
to its shareholders since becoming a publicly listed company on the
Toronto Stock Exchange.
_________________________________
|
(1)
|
Represents a non-IFRS
measure. See the Non-IFRS Measures section in this document and in
our MD&A for relevant information about such
measures.
|
Business Segment
Performance
Sagicor has three main reporting operating segments: Sagicor
Life (includes southern Caribbean), Sagicor Jamaica (of which the
Company owns 49.1% and which is consolidated by the Company), and
Sagicor Life USA.
Performance (US$
millions)
|
Q3
2022
|
Q3
2021
|
Change
(%)
|
YTD
2022
|
YTD
2021
|
Change
(%)
|
Total
revenue
|
|
|
|
|
|
|
Sagicor
Life
|
122.6
|
121.9
|
1 %
|
377.0
|
374.5
|
1 %
|
Sagicor
Jamaica
|
168.4
|
174.4
|
(3 %)
|
490.2
|
516.3
|
(5 %)
|
Sagicor Life
USA
|
356.7
|
465.5
|
(23 %)
|
1,136.5
|
782.7
|
45 %
|
Head
office(1)
|
8.4
|
20.1
|
(58 %)
|
5.3
|
56.1
|
(91 %)
|
Benefits and
expenses
|
|
|
|
|
|
|
Sagicor
Life
|
(122.8)
|
(113.2)
|
8 %
|
(356.3)
|
(349.6)
|
2 %
|
Sagicor
Jamaica
|
(137.5)
|
(106.1)
|
30 %
|
(402.0)
|
(398.6)
|
1 %
|
Sagicor Life
USA
|
(301.6)
|
(436.3)
|
(31 %)
|
(952.5)
|
(731.8)
|
30 %
|
Head
office(1)
|
(32.6)
|
(26.4)
|
23 %
|
(88.8)
|
(82.1)
|
8 %
|
Net income/(loss) to
shareholders
|
|
|
|
|
|
|
Sagicor
Life
|
(5.1)
|
7.0
|
(173 %)
|
13.7
|
22.1
|
(38 %)
|
Sagicor
Jamaica
|
12.6
|
27.1
|
(54 %)
|
32.8
|
44.0
|
(25 %)
|
Sagicor Life
USA
|
42.0
|
23.1
|
82 %
|
140.0
|
40.2
|
248 %
|
Head
office(1)
|
(24.1)
|
(6.8)
|
(254 %)
|
(84.0)
|
(15.1)
|
(456 %)
|
(1) Head office includes parent
company financing costs, administrative expenses, and the Company's
interest in Playa Hotels and Resorts, other, and
adjustments.
|
Business Segment - Quarterly
Highlights
Sagicor Life
- Total revenue including premiums of $122.6 million was up 1% Y/Y and net premium
revenue of $92.3 million increased 1%
Y/Y with growth observed in the life and health business partially
offset by a decline in the annuity business. Net investment income
was up 8% mainly due to increased interest income.
- Net loss to shareholders of $5.1
million largely attributable to a $7.3 million increase in benefits which included
negative claims experience and reserve strengthening, and a
one-time Pandemic Levy by the Government of Barbados of $3.9
million.
Sagicor Jamaica
- Total revenue including premiums of $168.4 million decreased 3% Y/Y mainly due to
unrealized mark-to-market losses on financial assets carried at
fair value through profit and loss. Net premium revenue of
$96.0 million increased 14% Y/Y as
the segment observed growth across all lines except from the
property and casualty insurance business which reported a slight
decline compared to the prior year. Interest income increased by
10% Y/Y during the quarter mainly due to rising interest
rates.
- Sagicor's share of Sagicor Jamaica's net income to
shareholders, was $12.6 million,
a decrease compared to the same quarter in the prior year which had
benefited from positive emergence in the annual review of actuarial
reserves.
Sagicor Life USA
- Total revenue including premiums of $356.7 million decreased 23% Y/Y driven by lower
sales. Net premium revenue was $329.4
million, a decrease of 25% Y/Y, as the segment modulated
sales of annuities as part of its strategy for deliberate growth
and scale. Interest income grew 89% Y/Y due to the continued strong
growth of the investment portfolio as a result of the additional
assets from strong sales.
- Net income to shareholders of $42.0 million increased by 82% compared to
$23.1 million for the same quarter in
the prior year, reflecting the present value of anticipated profits
from the significant volume of new annuities sold at favorable
investment spreads.
Head Office, Other and Adjustments
- Net loss to shareholders of $24.1
million includes the $7.3
million mark-to-market loss on the Company's shareholding in
Playa Hotels and Resorts, a $5.7
million gain on revaluation of the call option on the 5.3%
senior notes due 2028, and $4.5
million in one-time charges and expenses related to the
ivari transaction and restructuring charges.
Outlook
The Group's financial results in Q3 2022 continue to reflect an
unusual macroeconomic environment. Asset price volatility driven by
geopolitical instability, inflationary pressures and rising
interest rates created mark-to-market losses on Sagicor's balance
sheet. In addition, our Sagicor Life segment in particular
continues to operate in a challenging economic environment as
jurisdictions recover from the effects of the COVID-19 pandemic. On
the other hand, the rising rate environment enabled Sagicor to
continue to invest new policyholder funds at robust investment
spreads. The effects of global inflation and economic slowdown may
hamper economic growth in our core markets and may counteract an
improving forward outlook for tourism. We anticipate resuming
specific guidance with respect to earnings targets when the timing
of economic recovery becomes more certain.
Normal Course Issuer Bid
Sagicor repurchased 54,804 shares in Q3 2022 for a total cost of
approximately US$0.3 million. Since
the start of the program in June
2020, the Company has repurchased 8,049,897 shares in the
open market for cancellation for an aggregate purchase price of
approximately US$38.9 million. The
number of issued and outstanding common shares at September 30, 2022 was 142,811,034.
Management's Discussion and
Analysis and Consolidated Financial Statements
(Unaudited)
This press release, which was approved by the Company's Board of
Directors and Audit Committee, should be read in conjunction with
the Company's unaudited consolidated financial statements and
accompanying MD&A. The unaudited financial statements and
MD&A are available on the Company's website at www.sagicor.com
and will soon be filed on the System for Electronic Document
Analysis and Retrieval ("SEDAR") at www.sedar.com.
Conference Call
Sagicor Financial Company Ltd. will host a conference call for
analysts and investors on Wednesday,
November 16, 2022, at 2:00 p.m.
Eastern Standard Time in Toronto (3:00
p.m. Atlantic Standard Time in Barbados and Trinidad and Tobago, 2:00 p.m. Eastern Standard Time in Jamaica). To listen to the call via live audio
webcast, visit the Company's website at www.sagicor.com, under the
tab "Investor Relations." The conference call is also available by
dialing 1-416-764-8688 or 1-888-390-0546 (North American toll free)
or 08006522435 (United Kingdom) or
1-866-290-2216 (Barbados) or
1-800-207-8221 (Trinidad),
passcode 59042839. A replay will also be available until
December 17, 2022, by dialing
1-416-764-8677 or 1-888-390-0541 (North American toll free),
passcode 042839#. A transcript of the call will also be made
available on www.sagicor.com.
About Sagicor Financial Company
Ltd.
Sagicor Financial Company Ltd. (TSX: SFC) is a leading financial
services provider in the Caribbean, with over 180 years of history, and
has a growing presence as a provider of life insurance products in
the United States. On August 25, 2022, Sagicor announced that it
entered into a definitive agreement to acquire ivari, a leading
middle-market individual life insurer in Canada with over 80 years of history in the
region. Sagicor offers a wide range of products and services,
including life, health, and general insurance, banking, pensions,
annuities, and real estate. Sagicor's registered office is located
at Clarendon House, 2 Church Street, Hamilton, HM 11, Bermuda, with its principal office located at
Cecil F De Caires Building, Wildey, St.
Michael, Barbados.
Additional information about Sagicor can be obtained by visiting
www.sagicor.com.
Non-IFRS Measures
The Company reports certain non-IFRS measures that are used
to evaluate the performance of its businesses and the performance
of their respective segments. As non-IFRS measures generally do not
have a standardized meaning, they may not be comparable to similar
measures presented by other issuers. Securities regulators require
such measures to be clearly defined and reconciled with their most
comparable IFRS measure.
The Company references non-IFRS measures and insurance
industry metrics in this document and elsewhere. Non-IFRS measures
are not recognized measures under IFRS and do not have a
standardized meaning prescribed by IFRS and are therefore unlikely
to be comparable to similar measures presented by other companies.
Rather, these are provided as additional information to complement
those IFRS measures by providing further understanding of the
results of the operations of the Company from management's
perspective. Accordingly, these measures should not be considered
in isolation, nor as a substitute for analysis of the Company's
financial information reported under IFRS. Non-IFRS measures used
to analyze the performance of the Company's businesses include but
are not limited to: return on shareholders' equity, book value per
share, debt to capital ratio and total capital. Please see the
"Non-IFRS Financial Information" section of the MD&A and the
discussion below for a reconciliation of these non-IFRS
measures.
Return on Shareholders' Equity: IFRS does not
prescribe the calculation of return on shareholders' equity and
therefore a comparable measure under IFRS is not available. To
determine this measure, reported net income/(loss) attributable to
shareholders is divided by the total weighted average common
shareholders' equity for the period. The quarterly return on
shareholders' equity is annualised. The ROE provides an indication
of overall profitability of the Company.
Book value per share: To determine the book
value per share, shareholders' equity is divided by the number of
shares outstanding at the period end, net of any treasury
shares. All components of this measure are IFRS
measures.
Debt to capital ratio: The debt to capital
ratio is the ratio of notes and loans payable (refer to note 16 to
the 2021 audited consolidated financial statements) to total
capital (excluding participating accounts), where capital is
defined as the sum of notes and loans payable and total equity
excluding participating accounts. This ratio measures the
proportion of debt a company uses to finance its operations as
compared with its capital.
Total capital: This measure provides an
indicator for evaluating the Company's performance. Total capital
is the sum of shareholders' equity, notes and loans payable and
non-controlling interest. This measure is the sum of several IFRS
measures.
Minimum Continuing Capital and Surplus Requirements
(MCCSR): Sagicor voluntarily adopted the Canadian
Minimum Continuing Capital and Surplus Requirement ("MCCSR")
standard as its risk-based assessment measure to provide a
consolidated view of capital adequacy. The MCCSR was a standard
used by Canadian regulators from 1992 until 2018, when it was
superseded by the Life Insurance Capital Adequacy Test (LICAT).
When it was in place, the minimum standard recommended by the
Canadian regulators was an MCCSR of 150.0%. Canadian practices for
calculation of the MCCSR evolved and changed from inception through
its replacement. In jurisdictions where the MCCSR is currently
prescribed, such as Jamaica, the
MCCSR guidance is not consistent with the most recent Canadian
MCCSR guidelines or with current Canadian capital standards under
LICAT. Sagicor has made certain interpretations in our calculation
of the MCCSR, in consultation with our appointed actuary, which we
believe appropriately reflect the risk-based assessment of our
capital position. As the MCCSR is no longer prescribed by Canadian
regulators and is interpreted in different ways by our local
regulators, there can be no assurance that Sagicor's MCCSR figures
are comparable to current reporting by Canadian life insurers or
that of Canadian life insurers at any single point in time since
the implementation of the MCCSR. IFRS does not prescribe the
calculation for the MCCSR, therefore a comparable measure under
IFRS is not available.
Cautionary
Statements
Certain information contained in this news release may be
forward-looking statements within the meaning of Canadian
securities laws. Forward-looking statements are often, but not
always identified by the use of words such as "expect",
"anticipate", "believe", "foresee", "could", "estimate", "goal",
"intend", "plan", "seek", "will", "may", "would" and "should" and
similar expressions or words suggesting future outcomes. This news
release includes forward-looking information and statements
pertaining to the impact of the COVID-19 pandemic. These
forward-looking statements reflect material factors and
expectations and assumptions of Sagicor. Sagicor's estimates,
beliefs and assumptions are inherently subject to uncertainties and
contingencies regarding future events and as such, are subject to
change. Risks and uncertainties not presently known to Sagicor or
that it presently believes are not material could cause actual
results or events to differ materially from those expressed in its
forward-looking statements. Additional information on these and
other factors that could affect events and results are included in
other documents and reports that will be filed by Sagicor with
applicable securities regulatory authorities and may be accessed
through the SEDAR website (www.sedar.com). Readers are cautioned
not to place undue reliance on these forward-looking statements,
which reflect Sagicor's expectations only as of the date of this
document. Sagicor disclaims any obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, except as expressly required by
law.
SOURCE Sagicor Financial Company Ltd.